
Sisram Medical Ltd
HKEX:1696

Income Statement
Earnings Waterfall
Sisram Medical Ltd
Revenue
|
349.1m
USD
|
Cost of Revenue
|
-132.4m
USD
|
Gross Profit
|
216.7m
USD
|
Operating Expenses
|
-181.7m
USD
|
Operating Income
|
35m
USD
|
Other Expenses
|
-9.8m
USD
|
Net Income
|
25.1m
USD
|
Income Statement
Sisram Medical Ltd
Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||
Revenue |
66
N/A
|
137
+106%
|
215
+57%
|
154
-28%
|
161
+5%
|
174
+8%
|
160
-8%
|
162
+1%
|
216
+33%
|
294
+36%
|
344
+17%
|
354
+3%
|
352
-1%
|
359
+2%
|
356
-1%
|
349
-2%
|
|
Gross Profit | |||||||||||||||||
Cost of Revenue |
(30)
|
(64)
|
(100)
|
(72)
|
(72)
|
(78)
|
(73)
|
(72)
|
(94)
|
(127)
|
(149)
|
(152)
|
(144)
|
(140)
|
(137)
|
(132)
|
|
Gross Profit |
36
N/A
|
73
+103%
|
115
+57%
|
82
-28%
|
89
+9%
|
96
+7%
|
87
-9%
|
90
+4%
|
122
+35%
|
167
+37%
|
195
+17%
|
202
+4%
|
208
+3%
|
220
+6%
|
220
+0%
|
217
-1%
|
|
Operating Income | |||||||||||||||||
Operating Expenses |
(23)
|
(54)
|
(83)
|
(61)
|
(64)
|
(73)
|
(71)
|
(74)
|
(90)
|
(124)
|
(148)
|
(156)
|
(163)
|
(180)
|
(186)
|
(182)
|
|
Selling, General & Administrative |
(18)
|
(40)
|
(63)
|
(47)
|
(53)
|
(59)
|
(60)
|
(59)
|
(70)
|
(101)
|
(123)
|
(129)
|
(141)
|
(159)
|
(165)
|
(165)
|
|
Research & Development |
(5)
|
(12)
|
(17)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(14)
|
(16)
|
(16)
|
(18)
|
(19)
|
(18)
|
(17)
|
(16)
|
|
Other Operating Expenses |
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(3)
|
(1)
|
(4)
|
(5)
|
(8)
|
(10)
|
(9)
|
(3)
|
(2)
|
(4)
|
(1)
|
|
Operating Income |
13
N/A
|
19
+44%
|
32
+69%
|
22
-33%
|
26
+19%
|
23
-10%
|
16
-30%
|
17
+2%
|
32
+94%
|
43
+33%
|
47
+9%
|
46
-2%
|
45
-3%
|
40
-10%
|
34
-15%
|
35
+3%
|
|
Pre-Tax Income | |||||||||||||||||
Interest Income Expense |
(3)
|
(3)
|
(3)
|
1
|
(1)
|
2
|
(1)
|
(0)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
|
Pre-Tax Income |
11
N/A
|
16
+48%
|
29
+86%
|
23
-23%
|
25
+8%
|
25
+1%
|
16
-37%
|
17
+6%
|
30
+82%
|
42
+37%
|
45
+7%
|
44
-1%
|
42
-5%
|
37
-11%
|
31
-16%
|
33
+5%
|
|
Net Income | |||||||||||||||||
Tax Provision |
(3)
|
(5)
|
(7)
|
(1)
|
(0)
|
(3)
|
(2)
|
(2)
|
(4)
|
(9)
|
(9)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
Income from Continuing Operations |
8
|
11
|
22
|
22
|
24
|
22
|
14
|
15
|
26
|
33
|
36
|
40
|
38
|
33
|
27
|
29
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(0)
|
0
|
0
|
(1)
|
(4)
|
(4)
|
|
Net Income (Common) |
8
N/A
|
11
+41%
|
22
+102%
|
22
-2%
|
24
+9%
|
21
-13%
|
13
-37%
|
13
+2%
|
24
+81%
|
31
+29%
|
35
+14%
|
40
+13%
|
38
-4%
|
31
-18%
|
24
-25%
|
25
+7%
|
|
EPS (Diluted) |
0.02
N/A
|
0.04
+100%
|
0.06
+50%
|
0.05
-17%
|
0.05
N/A
|
0.05
N/A
|
0.03
-40%
|
0.03
N/A
|
0.05
+67%
|
0.07
+40%
|
0.08
+14%
|
0.09
+13%
|
0.08
-11%
|
0.07
-13%
|
0.05
-29%
|
0.05
N/A
|